Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
National HealthcareFRA:HTW -2.11%71 EV-to-EBIT is 17.86 as of Aug. 15, 2026, which is 31% above its 10-year median of 13.66. GuruFocus rates FRA:HTW with a GF Score™ of 71/100 and a GF Value™ of €111.35. The stock has 5 warning signs investors should review. Among 472 Healthcare Providers & Services companies, National Healthcare ranks worse than 57.2% on this metric.
The historical rank and industry rank for National Healthcare's EV-to-EBIT or its related term are showing as below:
FRA:HTW'
s EV-to-EBIT Range Over the Past 10 Years
Min: 5.08 Med: 13.66 Max: 52.23
Current: 17.71
During the past 13 years, the highest EV-to-EBIT of National Healthcare was 52.23. The lowest was 5.08. And the median was 13.66.
FRA:HTW's EV-to-EBIT is ranked worse than 57.2% of 472
companies
in the Healthcare Providers & Services industry
Industry Median: 15.715
vs FRA:HTW: 17.71
National Healthcare (FRA:HTW) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
National Healthcare's Enterprise Value for the quarter that ended in Jun. 2026 was €2,575 Mil.
National Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €162 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Healthcare EV-to-EBIT Related Terms
National Healthcare EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for National Healthcare's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, National Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
National Healthcare EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, National Healthcare's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where National Healthcare's EV-to-EBIT falls into.
National Healthcare's current Enterprise Value is €2,886 Mil.
National Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €162 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Healthcare (FRA:HTW) has a EV-to-EBIT of 17.86 as of Aug. 15, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on National Healthcare and its competitors. This is 31% above median its historical median of 13.66. Over the past decade, National Healthcare's EV-to-EBIT has ranged from 5.08 to 52.23. According to the industry distribution chart, National Healthcare ranks #270 out of 472 companies in the Healthcare Providers & Services industry, placing it in the top 57.2%.
Is National Healthcare's EV-to-EBIT too high?
National Healthcare's current EV-to-EBIT of 17.86 is 31% above median its 10-year median of 13.66. Over the past 10 years, this metric has ranged from a low of 5.08 to a high of 52.23. The Healthcare Providers & Services industry median EV-to-EBIT is 15.72. National Healthcare's value of 17.86 is 13.6% above this industry median. Based on the distribution chart, National Healthcare ranks #270 out of 472 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, National Healthcare has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does National Healthcare's EV-to-EBIT compare to BKD and OPCH?
According to the Healthcare Providers & Services industry distribution chart, National Healthcare ranks #270 out of 472 companies for EV-to-EBIT. This places National Healthcare in the lower half of its industry. The industry median EV-to-EBIT is 15.72. National Healthcare's value of 17.86 is 13.6% above this benchmark. Historically, National Healthcare's own EV-to-EBIT has ranged from 5.08 to 52.23 over the past decade. While the company's 10-year median is 13.66 vs. the industry median of 15.72, National Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.72, based on 472 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. National Healthcare's current EV-to-EBIT of 17.86 is 13.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on National Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. National Healthcare's current EV-to-EBIT is 17.86, which is 31% above median its own 10-year median of 13.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Healthcare stock overvalued right now?
National Healthcare (FRA:HTW) has a current EV-to-EBIT of 17.86. The stock's GF Value™ is €111.35, compared to a current price of €186.00 — trading 67% above its estimated fair value. The current EV-to-EBIT is 17.86, which is 31% above median its 10-year median of 13.66 and 13.6% above the Healthcare Providers & Services industry median of 15.72. National Healthcare's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For National Healthcare (FRA:HTW), the current EV-to-EBIT is 17.86 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is National Healthcare (FRA:HTW) Overvalued in 2026?
Based on GuruFocus' analysis, National Healthcare stock appears to be overvalued.
The current stock price of €186.00 is trading 67% above its estimated GF Value™ of €111.35.
Key valuation signals for FRA:HTW:
EV-to-EBIT: 17.86 (31% above median its 10-year median of 13.66)
GF Value™: €111.35 vs. price of €186.00 (67% above fair value)
Industry Position: 13.6% above the Healthcare Providers & Services median (#270 of 472)
No single metric tells the full story. See the FRA:HTW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.
71GF Score
Get the complete analysis for FRA:HTW
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HTW has been successfully added to your 
